Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
4DMedical Ltd ( (AU:4DX) ) has provided an update.
4DMedical has issued 70,064 fully paid ordinary shares under its Tax Exempt Employee Share Plan to qualifying employees, reinforcing its use of equity-based incentives to reward and retain staff. The company confirmed that the shares were issued without a prospectus in reliance on relevant Corporations Act provisions and stated it is fully compliant with its financial reporting and continuous disclosure obligations, with no undisclosed price-sensitive information, ensuring transparency and regulatory clarity for existing and potential shareholders.
The most recent analyst rating on (AU:4DX) stock is a Buy with a A$2.50 price target. To see the full list of analyst forecasts on 4DMedical Ltd stock, see the AU:4DX Stock Forecast page.
More about 4DMedical Ltd
4DMedical Limited is an Australian-listed medical technology company focused on lung health, developing and providing advanced imaging and analysis solutions aimed at improving diagnosis and management of respiratory conditions. The company operates internationally with a presence in Melbourne and Los Angeles, targeting healthcare providers and institutions involved in pulmonary care.
Average Trading Volume: 5,147,203
Technical Sentiment Signal: Buy
Current Market Cap: A$1.55B
See more data about 4DX stock on TipRanks’ Stock Analysis page.